Replacement of Fresh Embryo Transfers (ETs) by Frozen Embryo Transfers (FETs) Using Vitrification
Launched by YAZD RESEARCH & CLINICAL CENTER FOR INFERTILITY · Jan 14, 2009
Trial Information
Current as of June 14, 2025
Unknown status
Keywords
ClinConnect Summary
All patients in the initial cohort were treated with long protocol for ovarian stimulation. For pituitary down-regulation, patients were treated with daily administration of 0.5 mg buserelin (suprefact, Aventis, Frankfurt, Germany) from day 21 of menstrual cycle. Buserelin was reduced to 0.25 mg daily when ovaries were quiescent on ultrasound, and COH was initiated with recombinant FSH (Gonal F, Serono, Aubnne, Switzerland) 150 IU/day on day 2 of withdrawal bleeding. Serial ultrasound examinations and evaluation of serum E2 levels were used to assess ovarian response, and then gonadotropin ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • age \< 38
- • normal day 3 FSH
- • classified as high risk for OHSS
- • has ≥ 15 follicles with a mean diameter ≥ 12 mm per each ovary
- • E2 levels on the day of hCG administration \> 3000 pg/mL
- • undergoing her first assisted reproduction treatment cycle
- Exclusion Criteria:
- • who does not have good-quality embryos appropriate for cryopreservation
About Yazd Research & Clinical Center For Infertility
Yazd Research & Clinical Center for Infertility is a leading institution dedicated to advancing reproductive health through innovative research and clinical excellence. Situated in Yazd, Iran, the center specializes in the diagnosis and treatment of infertility, leveraging cutting-edge technologies and evidence-based practices to improve patient outcomes. With a commitment to scientific inquiry and patient care, the center conducts rigorous clinical trials aimed at enhancing reproductive techniques and expanding treatment options for individuals and couples facing infertility challenges. Its multidisciplinary team of experts collaborates to ensure the highest standards of care while contributing valuable insights to the field of reproductive medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yazd, , Iran, Islamic Republic Of
Patients applied
Trial Officials
abbas aflatoonian, M.D.
Principal Investigator
Research and Clinical Center for Infertility
homa oskouian, M.D.
Principal Investigator
Research and Clinical Center for Infertility
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials